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Background: Since the new 2009 guidelines for left subclavian artery (LSA) management using thoracic
endovascular aortic repair (TEVAR), a few studies have been published about alternative LSA management. The
objective of this study was to present the follow-up results of covered or revascularized LSA during TEVAR.
Methods: From January 2010 to August 2012, 109 consecutive patients were treated with TEVAR at the Department of
Vascular Surgery, Changhai Hospital, for aortic dissection extending near the LSA. After evaluating the bilateral vertebral
arteries, fifty-two LSAs were covered and not revascularized (covered group), while 57 LSAs were preserved
(revascularized group). Complications were stratified according to the time of occurrence after surgery.
Results: Emergency operations were more common (17.3 vs. 3.5 %, P = 0.017) and operation time was shorter
(96.9 ± 16.3 vs. 135.3 ± 38.4 min, P < 0.001) in the covered group. Pulselessness and intermittent claudication of the left
arm occurred in most patients in the covered group (P < 0.001). Incidence of stroke and cold shoulder feeling were
higher in the covered group compared with the revascularized group (P = 0.026 and <0.001, respectively). There were
five aorta-related deaths in the covered group and one in the revascularized group. Eight endoleaks were observed in
the revascularized group (P = 0.006).
Conclusions: The results of this study suggest that due to occurrence of complications, LSA should be preserved or
revascularized to reduce complications and to improve patients’ quality of life.
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Aortic dissection is the disruption of the aortic media
with bleeding within and along the aortic wall resulting
in separation of aortic layers [1]. About two thirds of
acute aortic dissections occur in men and in patients
aged >60 years [2, 3]. Estimated annual incidence of
aortic dissection is 2–6 per 100,000 individuals [4, 5].
Risk factors are hypertension, direct blunt trauma, pheo-
chromocytoma, cocaine use, weight lifting, aorta coarcta-
tion, and some genetic syndromes [1, 2]. Aortic dissection* Correspondence: luqs@xueguan.net; xueguanky@163.com
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creativecommons.org/publicdomain/zero/1.0/may result in aortic rupture, aortic valve insufficiency,
end-organ complications, and death [1, 2].
The advent of thoracic endovascular aortic repair
(TEVAR) has altered the management algorithm for aortic
dissections [6]. The increased use of TEVAR has been
driven by advantages reported in older patients with
greater comorbidities who have been judged unfit for dir-
ect open surgery and optimal medication regimens [7, 8].
An adequate length of proximal landing zone is a pre-
requisite for endovascular therapy [9]. Therefore, covering
the left subclavian artery (LSA) with a thoracic stent graft to
achieve an adequate landing zone is sometimes inevitable.
However, there is a controversy in the literature regarding
whether to simply cover the LSA or to revascularize it. Sev-
eral studies have concluded that the risks associated withticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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tery bypass could be performed in cases of obvious post-
operative complications, such as the presence of left arm
claudication or vertebrobasilar insufficiency [10–13]. Con-
versely, other studies identified an increased risk of neuro-
logic complications, specifically strokes and spinal cord
ischemia following LSA coverage [14–16].
In 2009, the Society for Vascular Surgery published
the clinical practice guidelines for LSA management
during TEVAR [17]. The guidelines proposed three rec-
ommendations to address the LSA. The first two guide-
lines are for elective TEVAR and suggest revascularization
is the most suitable method. The third recommendation
suggests that revascularization should be individualized
and addressed on the basis of anatomy, urgency and avail-
ability of surgical expertise to patients who need very ur-
gent TEVAR for life-threatening acute aortic syndromes
where achievement of a proximal seal necessitates
coverage of the LSA. However, revascularization can be
performed after emergency TEVAR. Therefore, these
guidelines do not answer the controversy, and more re-
sults are needed to assess this point.
On the basis of our previous experience in endovascu-
lar treatment and the branches of aortic arch [18–22],
the present study aimed to assess the outcomes of pa-
tients who underwent TEVAR for aortic dissection and
compare the outcomes of patients who had their LSA
covered with those who had revascularized LSA.
Methods
Patients
This was a single-center retrospective study of patients
with aortic dissection treated by TEVAR (n = 109) at the
Vascular Surgery Department of Changhai Hospital,
Shanghai, China, between January 2010 and August
2012. The study protocol was approved by the Ethics
Committee of the hospital, and the need for individual
consent was waived by the committee.
Aortic dissection diagnosis was confirmed by com-
puted tomography angiography (CTA) [1, 2]. Indications
for TEVAR were: (1) complicated aortic dissection, (2)
symptomatic penetrating aortic ulcer, or (3) complete
transection of the aortic wall and free bleeding [23].
The inclusion criteria were: (1) an aortic dissection diag-
nosis and (2) the patient underwent TEVAR. The
exclusion criteria were: (1) congenital connective tissue
diseases such as Marfan syndrome, (2) previous open sur-
gery or endovascular therapy for aortic diseases, (3) intra-
mural hematoma, or (4) asymptomatic penetrating ulcers.
Study design
Patients were stratified into two groups according to
LSA management. Fifty-two LSAs were covered and not
revascularized (covered group). Fifty-seven LSAs werepreserved (revascularized group) through bypass grafting
[24], scallop or fenestration techniques [25], chimney
techniques [19, 26, 27], or single-branch techniques [17].
Outcome and follow-up
All patients were followed up with CTA of the aorta and
the branches of the aortic arch at 6-month intervals for
the first year and then once annually. The primary
adverse events were stroke, paraplegia, and death.
Follow-up was censored on December 2013.
Statistical analysis
Statistical analysis was performed using SPSS 19.0 (IBM,
Armonk, NY, USA). Categorical variables are presented
as numbers and proportions, and were analyzed using
chi-square or Fisher’s exact tests, as appropriate. Continu-
ous variables are presented as means ± standard devia-
tions or as median (range) and were analyzed using t tests
or nonparametric tests, as appropriate. Event-free survival
was analyzed using the Kaplan-Meier method and curves
were compared using the log-rank test. Two-tailed P
values <0.05 were considered significant.
Results
Patient characteristics
Patient characteristics are presented in Table 1. The
mean age at onset was 56.2 ± 9.6 years, and majority of
the patients were male (86.2 %). Ten patients were older
than 70 years of age. The mean body mass index was
23.8 ± 3.2 kg/m2. Ninety-three patients had a history of
hypertension, and 41 patients were smokers at the time
of admission. Associated comorbidities were chronic
obstructive pulmonary disease (n = 7), diabetes mellitus
(n = 11), stroke (n = 4), myocardial infarction (n = 9), and
angina (n = 5). The proximal entry tears were located in
the proximal descending aorta in 62 patients, in the arch in
32 patients, and in the ascending aorta in 15 patients. Three
patients underwent preoperative hemodialysis, and one pa-
tient had preexisting congestive heart failure in the revascu-
larized group. Two patients had renal failure and seven
patients had pneumonia. General anesthesia was adminis-
tered to 10 patients in the covered group and 14 in the
revascularized group. The number of emergency proce-
dures was nine in the covered group and two in the revas-
cularized group (P = 0.017). The time taken for the surgical
procedure was 96.9 ± 16.3 min in the covered group and
135.3 ± 38.4 min in the revascularized group (P < 0.001).
Indications for alternative management of the LSA
The reasons for alternative management of the LSA are
presented in Table 2. There were 38 patients (including
five emergency procedures) with a dominant right vertebral
artery confirmed by preoperative CTA. Eleven patients
(including four emergency procedures) had equipotent
Table 1 Patient characteristics
Variable Overall Covered group Revascularized group P value
n (%) 109 n = 52 (47.7) n = 57 (52.3)
Demographic/anthropometric factors
Age, years 56.2 ± 9.6 55.5 ± 10.5 56.5 ± 9.3 0.636
Age >70, n (%) 10 (9.2) 6 (11.5) 4 (7.0) 0.514
Male, n (%) 94 (86.2) 43 (82.7) 51 (89.5) 0.305
Body mass index, kg/m2 23.8 ± 3.2 23.3 ± 2.0 24.0 ± 3.7 0.345
Medical history, n (%)
Hypertension 93 (85.3) 43 (82.7) 50 (87.7) 0.459
Current smoker 41 (37.6) 24 (46.2) 17 (29.8) 0.079
Chronic obstructive pulmonary disease 7 (6.4) 5 (9.6) 2 (3.5) 0.255
Diabetes mellitus 11 (10.1) 6 (11.5) 5 (8.8) 0.632
Stroke 4 (3.7) 3 (5.8) 1 (1.8) 0.346
Myocardial infarction 9 (8.3) 4 (7.7) 5 (8.8) >0.999
Angina 5 (4.6) 3 (5.8) 2 (3.5) 0.668
Preoperative hemodialysis 3 (2.8) 0 3 (5.3) 0.245
Congestive heart failure 1 (0.9) 0 1 (1.8) >0.999
Acute preoperative conditions, n (%)
Renal failure 2 (1.8) 0 2 (3.5) 0.496
Pneumonia 7 (6.4) 4 (7.7) 3 (5.3) 0.707
Procedural characteristics, n (%)
Emergent procedure 11 (10.1) 9 (17.3) 2 (3.5) 0.017
Traumatic aortic dissection 1 (0.9) 1 (1.9) 0 0.477
General anesthesia 24 (22.0) 10 (19.2) 14 (24.6) 0.502
Operation time (min) 122.6 ± 37.4 96.9 ± 16.3 135.3 ± 38.4 <0.001
Table 2 Indications for alternative management of the left




Dominant right vertebral artery (including 5
emergency procedures)
38 (34.9)
Bilateral vertebral artery equipotential (including
4 emergency procedures)
11 (10.1)




Dominant left vertebral artery (including 2
emergency procedures)
41 (37.6)
Occluded right vertebral artery 3 (2.7)
Planned long-segment coverage of the descending
thoracic aorta
5 (4.7)
A functioning arteriovenous shunt in the left arm 3 (2.7)
Patent left internal mammary artery to coronary
artery bypass graft
2 (1.9)
Bilateral internal carotid artery stenosis 3 (2.7)
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were included in the covered group. The revascularized
group was composed of 41 patients (including two emer-
gency procedures) with a dominant left vertebral artery.
Three patients who underwent preoperative hemodialysis
had a functional arteriovenous shunt in the left arm.
Other indications for revascularization of the LSA in-
cluded an occluded right vertebral artery (n = 3), planned
long-segment coverage of the descending thoracic aorta
(n = 5), patent left internal mammary artery to coronary
artery bypass graft (n = 2), and bilateral internal carotid
artery stenosis (n = 3).
Selection of revascularization method
The methods selected to preserve the LSA in the revas-
cularized group are shown in Table 3. Eleven patients
underwent bypass grafting, six the scallop or fenestration
techniques, 12 the chimney approach, and 28 received
single-branched stent grafts.
Complications observed during follow-up periods
The median follow-up period was 34 months, ranging
from 16 to 48 months. All of the preserved subclavian
Table 3 Method of revascularization for revascularized patients
Mode of revascularization n (%)
n = 57
Carotid-subclavian bypass or transposition 11 (19.3)
Scallop or fenestration 6 (10.5)
Chimney 12 (21.1)
Single-branched stent grafts 28 (49.1)
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tears were successfully occluded. No access site compli-
cations occurred. Complete thrombus formation in the
false lumen of the aorta was demonstrated in all pa-
tients, and significant true lumen recovery and false
lumen shrinkage were demonstrated in the aorta.
Complications during follow-up are presented in
Table 4. Two strokes happened on the third and sixth
day after the procedures, and five were observed during
the mid- to long-term follow-up periods in the covered
group (P = 0.026). Forty-six cases of pulselessness were
observed; the patients had Doppler signals but no palpable
pulses of the radial artery (P < 0.001), and twenty-four pa-
tients in the covered group suffered from intermittent
claudication of the left arm when they performed physical
activity (P < 0.001). Fifteen and two patients complained
of a cold shoulder feeling in the covered group and revas-
cularized group, respectively (P < 0.001). There was an
aorta-related death in the covered group on the seventh
day; the four other deaths in the group occurred on the
second, fourth, fifth, and seventh month after the proced-
ure. No abovementioned complication occurred in the
revascularized group during short-term follow-up. How-
ever, some complications occurred during the mid- to
long-term follow-up. Paraplegia was observed in four and
two patients in the covered group vs. the revascularized
group, respectively. A significant difference in endoleak
occurrence was observed between the two groups (0 vs. 8,
P = 0.006). The number of complications in the covered
group was much higher compared with the revascular-
ized group. In addition, patients in the covered groupTable 4 All complications during follow-up






Stroke 2 5 7 (13.5)
Paraplegia 1 3 4 (7.7)
Pulselessness of left arm 3 43 46 (88.5
Endoleak 0 0 0
Intermittent claudication
of left arm
4 20 24 (46.2
Cold shoulder feeling 2 13 15 (28.8
Aorta-related death 1 4 5 (9.6)developed more complications in the third and sixth
month after TEVAR, while the highest number of com-
plications in the revascularized group occurred in the
second month after TEVAR.
In the covered group, coils were used as an adjunctive
technique in 16 patients; this method was used if a type
II endoleak was caused by collateral reflux. The LSA ori-
fice was then occluded by coils after puncturing the left
brachial artery. We compared complication rates in the
subgroup of patients treated with coils compared to
those treated without coils but found there was no sig-
nificant difference between them (Table 5).
To evaluate whether the entry point location had an
influence on the complication rate, we compared the
number of complications for patients subgrouped ac-
cording to the location of entry tears. The data are pre-
sented in Table 5 and show that there was no significant
difference between them.
Figure 1 presents event-free survival. Compared with
the covered group, the revascularized group had a better
4-year event-free survival (93.0 vs. 69.2 %, P = 0.002).
During follow-up, twelve patients in the covered group
underwent revascularization of the LSA to improve their
quality of life.
Discussion
The objective of the present study was to present the
follow-up results of covered or revascularized LSA during
TEVAR. The results showed that emergency operations
were more common and operation time was shorter in
the covered group. Pulselessness and intermittent claudi-
cation of the left arm occurred in most patients in the
covered group. The incidence of stroke and cold shoulder
feeling were higher in the covered group compared with
the revascularized group. There were five aorta-related
deaths in the covered group and two in the revascularized
group. Eight endoleaks were observed in the revascular-
ized group.
To avoid complications induced by stent-graft migra-








0 1 1 (1.8) 0.026
1 1 2 (3.5) 0.422
) 0 0 0 <0.001
2 6 8 (14) 0.006
) 0 0 0 <0.001
) 0 2 2 (3.5) <0.001
0 1 1 (1.8) 0.101
Table 5 Major complications related with coils and location of entry tears during the follow-up period
Complications Covered group (n = 52) P Location of entry tears in all patients (n = 109) P
With coils Without coils Ascending aorta Aortic arch Descending aorta
(n = 16) (n = 36) (n = 15) (n = 32) (n = 62)
Stroke 3 (18.8) 4 (11.4) 0.662 2 (13.3) 4 (12.5) 2 (3.2) 0.166
Paraplegia 2 (12.5) 2 (5.6) 0.578 1 (6.7) 1 (3.1) 4 (6.5) 0.781
Aorta-related death 3 (18.8) 2 (5.6) 0.163 0 2 (6.3) 4 (6.5) 0.602
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this proximal landing zone involves covering the LSA
[28]. However, the management of the LSA in the
setting of intentional coverage during TEVAR remains
controversial.
In 2009, the Society for Vascular Surgery developed
the clinical practice guidelines for the management of
the LSA with TEVAR and offered three main recom-
mendations [17]. In the present study, different treat-
ment strategies were used after evaluating the patients’
conditions and blood supply, based on the three recom-
mendations from the guidelines. Results showed that
most non-revascularized patients had left arm complica-
tions, such as pulselessness and intermittent claudication.
In addition, over-stenting of the LSA without revasculari-
zation was associated with a relatively high incidence of
stroke and a cold shoulder feeling compared with patients
who underwent preoperative revascularization of the LSA.
The left vertebral artery originating from the LSA is a
primary component of the vertebrobasilar artery, whichFig. 1 Kaplan-Meier curves of event-free survival in the covered and revascdivides into two posterior cerebral arteries and supplies
two fifths of the blood to the brain [10]. More than 60 %
of individuals have a dominant left vertebral artery,
which has been used to justify routine preoperative LSA
revascularization [15, 17, 29]. In addition, the guidelines
underline that the LSA may be covered upon certain
conditions [17]. Even in the absence of life-threatening
symptoms, some benign symptoms may lower patients’
quality of life.
No other organ suffers more readily from an irrevers-
ible attack than the brain when its blood supply is insuf-
ficient. In those patients with a dominant right vertebral
artery or equipotent bilateral vertebral arteries, covering
the LSA would be devastating in the event of right verte-
bral artery stenosis or occlusion, such as by a thrombus
resulting from atrial fibrillation. Indeed, the LSA is the
primary artery to the left arm and a source of blood flow
to the brain and spinal cord. Given the extensive circula-
tion provided by the LSA, covering the LSA during
TEVAR may not be inconsequential, which is associatedularized groups. Events were defined as stroke, paraplegia, or death
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spinal cord ischemia compared with patients whom this
artery is not covered [8, 13, 15, 30]. A multicenter regis-
try analysis concluded that the incidence of paraplegia
due to spinal cord ischemia and stroke was higher in
LSA-covered patients than in those who received
prophylactic revascularization [31].
The guidelines suggest that the LSA must be revascu-
larized in some situations [17] such as bilateral internal
carotid artery disease, isolated left brain hemisphere, and
an incomplete circle of Willis. In the present study, one
patient was referred to our center urgently, eliminating
the possibility of revascularizing the LSA. Unfortunately,
the patient died on the seventh day after the emergency
procedure due to an acute cerebral infarction. It is pos-
sible that this patient would have survived if postopera-
tive revascularization had been performed.
The present study is not without limitations. First, it
was a retrospective study performed in a small number
of patients. In addition, a number of different approaches
were used to revascularize the LSA, which could lead to
bias. However, the present study analyzed the patients as
patent/non-patent LSA. Further large multi-center studies
are required to assess these points.
Conclusions
Some complications were observed when covering the
LSA during TEVAR. Therefore, the LSA should be
preserved or revascularized if possible, whether preopera-
tively or postoperatively. In patients who are referred
urgently, a postoperative revascularization should be exe-
cuted when possible.
Abbreviations
CTA: computed tomography angiography; LSA: left subclavian artery;
TEVAR: thoracic endovascular aortic repair.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LZ participated in the conception and design, data collection, analysis and
interpretation, and statistical analysis and wrote the manuscript. QSL and ZPJ
participated in the conception and design and data collection, obtained funding,
provided critical revision of the article, and take overall responsibility for this study.
JZ and ZQZ participated in the data collection, analysis and interpretation, and
statistical analysis and provided critical revision of the article. JMB participated in
the data collection and analysis and interpretation and provided critical revision of
the article. All authors read and approved the final manuscript.
Acknowledgements
Qingsheng Lu, MD, was supported by National Natural Science Foundation
of China (81170291) and the 1255 Project of Changhai Hospital (125550300);
Zaiping Jing, MD, PhD, was supported by Key Program of National Natural
Science Foundation of China (81330034) and the 1255 Project of Changhai
Hospital (125520200).
Received: 26 December 2014 Accepted: 23 May 2015References
1. Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey Jr DE, et al.
2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the
diagnosis and management of patients with Thoracic Aortic Disease: a
report of the American College of Cardiology Foundation/American Heart
Association Task Force on Practice Guidelines, American Association for
Thoracic Surgery, American College of Radiology, American Stroke
Association, Society of Cardiovascular Anesthesiologists, Society for
Cardiovascular Angiography and Interventions, Society of Interventional
Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine.
J Am Coll Cardiol. 2010;55:e27–e129.
2. Ramanath VS, Oh JK, Sundt 3rd TM, Eagle KA. Acute aortic syndromes and
thoracic aortic aneurysm. Mayo Clin Proc. 2009;84:465–81.
3. Nienaber CA, Fattori R, Mehta RH, Richartz BM, Evangelista A, Petzsch M,
et al. Gender-related differences in acute aortic dissection. Circulation.
2004;109:3014–21.
4. Clouse WD, Hallett Jr JW, Schaff HV, Spittell PC, Rowland CM, Ilstrup DM,
et al. Acute aortic dissection: population-based incidence compared with
degenerative aortic aneurysm rupture. Mayo Clin Proc. 2004;79:176–80.
5. Howard DP, Banerjee A, Fairhead JF, Perkins J, Silver LE, Rothwell PM, et al.
Population-based study of incidence and outcome of acute aortic dissection
and premorbid risk factor control: 10-year results from the Oxford Vascular
Study. Circulation. 2013;127:2031–7.
6. Patterson B, Holt P, Nienaber C, Cambria R, Fairman R, Thompson M. Aortic
pathology determines midterm outcome after endovascular repair of the
thoracic aorta: report from the Medtronic Thoracic Endovascular Registry
(MOTHER) database. Circulation. 2013;127:24–32.
7. Walsh SR, Tang TY, Sadat U, Naik J, Gaunt ME, Boyle JR, et al. Endovascular
stenting versus open surgery for thoracic aortic disease: systematic review
and meta-analysis of perioperative results. J Vasc Surg. 2008;47:1094–8.
8. Jonker FH, Verhagen HJ, Lin PH, Heijmen RH, Trimarchi S, Lee WA, et al.
Open surgery versus endovascular repair of ruptured thoracic aortic
aneurysms. J Vasc Surg. 2011;53:1210–6.
9. Dake MD. Endovascular stent-graft management of thoracic aortic diseases.
Eur J Radiol. 2001;39:42–9.
10. Dexter D, Maldonado TS. Left subclavian artery coverage during TEVAR: is
revascularization necessary? J Cardiovasc Surg (Torino). 2012;53:135–41.
11. Antonello M, Menegolo M, Maturi C, Dall'antonia A, Lepidi S, Frigo AC, et al.
Intentional coverage of the left subclavian artery during endovascular repair of
traumatic descending thoracic aortic transection. J Vasc Surg. 2013;57:684–90.
12. Caronno R, Piffaretti G, Tozzi M, Lomazzi C, Rivolta N, Castelli P. Intentional
coverage of the left subclavian artery during endovascular stent graft repair
for thoracic aortic disease. Surg Endosc. 2006;20:915–8.
13. Rizvi AZ, Murad MH, Fairman RM, Erwin PJ, Montori VM. The effect of left
subclavian artery coverage on morbidity and mortality in patients
undergoing endovascular thoracic aortic interventions: a systematic review
and meta-analysis. J Vasc Surg. 2009;50:1159–69.
14. Chung J, Kasirajan K, Veeraswamy RK, Dodson TF, Salam AA, Chaikof EL,
et al. Left subclavian artery coverage during thoracic endovascular aortic
repair and risk of perioperative stroke or death. J Vasc Surg. 2011;54:979–84.
15. Cooper DG, Walsh SR, Sadat U, Noorani A, Hayes PD, Boyle JR. Neurological
complications after left subclavian artery coverage during thoracic
endovascular aortic repair: a systematic review and meta-analysis. J Vasc
Surg. 2009;49:1594–601.
16. Weigang E, Parker JA, Czerny M, Lonn L, Bonser RS, Carrel TP, et al. Should
intentional endovascular stent-graft coverage of the left subclavian artery
be preceded by prophylactic revascularisation? Eur J Cardiothorac Surg.
2011;40:858–68.
17. Matsumura JS, Lee WA, Mitchell RS, Farber MA, Murad MH, Lumsden AB,
et al. The Society for Vascular Surgery Practice Guidelines: management of
the left subclavian artery with thoracic endovascular aortic repair. J Vasc
Surg. 2009;50:1155–8.
18. Lu Q, Feng J, Zhou J, Zhao Z, Bao J, Feng R, et al. Endovascular repair of
ascending aortic dissection: a novel treatment option for patients judged
unfit for direct surgical repair. J Am Coll Cardiol. 2013;61:1917–24.
19. Feng R, Zhao Z, Bao J, Wei X, Wang L, Jing Z. Double-chimney technology
for treating secondary type I endoleak after endovascular repair for
complicated thoracic aortic dissection. J Vasc Surg. 2011;54:212–5.
20. Yuan L, Bao J, Zhao Z, Jing Z. Repeat endovascular exclusion for distal tear
after treatment of primary aortic dissection by endovascular exclusion.
Vascular. 2010;18:288–91.
Zhang et al. European Journal of Medical Research  (2015) 20:57 Page 7 of 721. Zhang J, Jing Z, Feng X, Mei Z. Combined open and endovascular repair of
a DeBakey type IIIb dissection with complete distal true lumen occlusion.
Am Surg. 2010;76:659–61.
22. Yuan L, Feng X, Jing Z. Endovascular repair of a thoracic arch aneurysm
with a fenestrated stent-graft. J Endovasc Ther. 2008;15:539–43.
23. Grabenwoger M, Alfonso F, Bachet J, Bonser R, Czerny M, Eggebrecht H,
et al. Thoracic endovascular aortic repair (TEVAR) for the treatment of aortic
diseases: a position statement from the European Association for Cardio-Thoracic
Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration
with the European Association of Percutaneous Cardiovascular Interventions
(EAPCI). Eur Heart J. 2012;33:1558–63.
24. Chan YC, Cheng SW, Ting AC, Ho P. Supra-aortic hybrid endovascular
procedures for complex thoracic aortic disease: single center early to
midterm results. J Vasc Surg. 2008;48:571–9.
25. Numan F, Arbatli H, Bruszewski W, Cikirikcioglu M. Total endovascular aortic
arch reconstruction via fenestration in situ with cerebral circulatory support:
an acute experimental study. Interact Cardiovasc Thorac Surg. 2008;7:535–8.
26. Criado FJ. A percutaneous technique for preservation of arch branch
patency during thoracic endovascular aortic repair (TEVAR): retrograde
catheterization and stenting. J Endovasc Ther. 2007;14:54–8.
27. Hiramoto JS, Schneider DB, Reilly LM, Chuter TA. A double-barrel stent-graft
for endovascular repair of the aortic arch. J Endovasc Ther. 2006;13:72–6.
28. Kotelis D, Geisbusch P, Hinz U, Hyhlik-Durr A, von Tengg-Kobligk H, Allenberg
JR, et al. Short and midterm results after left subclavian artery coverage during
endovascular repair of the thoracic aorta. J Vasc Surg. 2009;50:1285–92.
29. Feezor RJ, Martin TD, Hess PJ, Klodell CT, Beaver TM, Huber TS, et al. Risk
factors for perioperative stroke during thoracic endovascular aortic repairs
(TEVAR). J Endovasc Ther. 2007;14:568–73.
30. Rehman SM, Vecht JA, Perera R, Jalil R, Saso S, Kidher E, et al. How to
manage the left subclavian artery during endovascular stenting for thoracic
aortic dissection? An assessment of the evidence. Ann Vasc Surg.
2010;24:956–65.
31. Buth J, Harris PL, Hobo R, van Eps R, Cuypers P, Duijm L, et al. Neurologic
complications associated with endovascular repair of thoracic aortic
pathology: Incidence and risk factors. a study from the European
Collaborators on Stent/Graft Techniques for Aortic Aneurysm Repair
(EUROSTAR) registry. J Vasc Surg. 2007;46:1103–10.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
